ACTINIUM PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $4.60M, a 60.92% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $9.96M, a 1.73% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $14.70M, a 1808.44% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $2.86M, a 81.31% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2024 was $29.25M, a 100.21% increase from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2023 was $14.61M, a 36.90% decline from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2022 was $23.16M.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2020 was $76.59M, a 380.72% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $29.25M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $4.60M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $9.96M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $14.70M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $14.61M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $2.86M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $9.79M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $770.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $23.16M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $1.58M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $16.69M 10-Q · filed 2023-11-02 | |
| 2021-09-30 | $5.80M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $14.32M 10-Q · filed 2021-11-12 | |
| 2021-03-31 | $14.36M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $76.59M 10-K · filed 2022-03-25 | |
| 2020-03-31 | $2.67M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $15.93M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $444.11K 10-Q · filed 2019-11-12 | |
| 2019-03-31 | $380.00K 10-Q · filed 2020-10-23 | |
| 2015-12-31 | $35.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $37.64M 10-K · filed 2016-03-11 |
| 2015-09-30 | -$5.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | |
| 2015-06-30 | $7.74M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $6.00K derived: 10-K 12 month − 3 quarters · filed 2016-03-11 | |
| 2014-12-31 | $15.44M 10-K · filed 2016-03-11 | |
| 2014-04-28 | $6.00K 10-K · filed 2015-03-16 | |
| 2013-12-31 | $2.88M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |